mTOR- and tyrosine kinase inhibitors reduce AKT- and IGF-R expression in squamous cell carcinoma (HNSCC), dependent on p16 status - Kuhlin, B; Kramer, B; Rotter, N; Aderhold, C (Laryngo-Rhino-Otologie, 2018)